Beximco Pharmaceuticals PLC. BXP.L

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-06-30

Average Intrinsic Value
$811.93M
Market Cap
$313.54M
Margin of Safety
61.4%
Intrinsic / Market Ratio
2.59

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

795.70M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

888.83M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

751.27M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

811.93M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

811.93M USD

from the sum above

Market Cap

313.54M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

2.59×

the ratio the screener ranks by; Margin of Safety +61.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 795.70M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)779.14M USD
+②Net Cash Today16.56M USD
+③Growth Value0 USD
=Value795.70M USD

EPV of the Operations (NOPAT over WACC)

779.14M USD

Net cash today

+16.56M USD

Growth Value

0 USD

Value

795.70M USD

①EPV (earnings power value)

779.14M USD

②Net Cash Today

16.56M USD

③Growth Value

0 USD

Market value

Market Cap313.54M USD

Today's price times the shares.

Value vs market

Margin of Safety+60.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 888.83M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE421.34M USD
+②Equity at Year 15, Today467.49M USD
=Value888.83M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

421.34M USD

②Equity at Year 15, Today

467.49M USD

Market value

Market Cap313.54M USD

Today's price times the shares.

Value vs market

Margin of Safety+64.7%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 751.27M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF479.16M USD
+②Invested Capital at Year 15, Today255.54M USD
+③Net Cash Today16.56M USD
=Value751.27M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

479.16M USD

②Invested Capital at Year 15, Today

255.54M USD

③Net Cash Today

16.56M USD

Market value

Market Cap313.54M USD

Today's price times the shares.

Value vs market

Margin of Safety+58.3%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.67%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.30×Market Risk Premium 6.00%= 6.32%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 16.63M USDPretax Income 74.68M USD= 22.27%

The tax the interest saves.

Interest Expense =EBIT 82.68M USD−Pretax Income 74.68M USD= 8.00M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 8.00M USDTotal Debt 26.01M USD×(1 − Tax Rate for WACC 22.27%)= 23.90%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 26.01M USDMarket Cap + Total Debt 313.54M USD + 26.01M USD= 7.66%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 92.34%×Cost of Equity 6.32%+Debt Weight 7.66%×Cost of Debt 23.90%= 7.67%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 647.32M USD − Total Liabilities 120.33M USD = Book Value Today 527.00M USD

Total Debt 26.01M USD − Cash and Short-Term Investments 42.57M USD = Net Debt Today -16.56M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes446,112,089 / 446,112,089
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets0.4%at least -10.0%passes(59.91M USD − 57.57M USD) ÷ 647.32M USD
Price to bookMarket Cap ÷ Book Value Today0.59×at most 3×passes313.54M USD ÷ 527.00M USD
Operating marginOperating Income ÷ Revenue19.6%above 10.0%passes79.79M USD ÷ 407.43M USD
Revenue growthRevenue ÷ Revenue a Year Before − 16.2%above 10.0%does not pass407.43M USD / 383.55M USD
Net cash(Cash − Total Debt) ÷ Market Cap2.8%above -30%passes(34.76M USD − 26.01M USD) ÷ 313.54M USD
Operating efficiencyOperating Income ÷ Gross Profit43.1%above 25.0%passes79.79M USD ÷ 184.94M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

53 USD

Enterprise value

—

market cap plus net debt

EV / EBITDA

—

Price / book

0.00×

the provider's book

Price / earnings

4.38×

Return on equity

14.7%

the provider's, not the engine's

Profit margin

16.0%

Revenue growth

8.1%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

378.49M369.01M383.55M407.43M

Gross profit

172.71M162.62M169.64M184.94M

Operating income

74.74M67.41M74.21M79.79M

EBITDA

operating income before depreciation and amortisation

101.31M88.06M91.93M99.41M

Pretax income

73.00M57.03M65.02M74.68M

Net income

55.93M43.36M50.37M57.57M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

56.32M43.28M50.37M57.38M

R&D

75.84K27.35K25.92K70.90K
Balance sheet, year end

Total assets

722.16M649.90M599.14M607.55M

Total liabilities

234.85M202.39M150.69M134.06M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

443.25M410.49M414.30M440.50M

Total debt

135.05M99.72M52.06M41.19M

Cash and equivalents

12.76M10.67M7.38M14.10M

Net PP&E

fixed assets after depreciation

453.55M402.28M371.95M365.19M

Working capital

current assets less current liabilities

62.05M71.52M97.25M127.68M
Cash flow

Operating cash flow

56.92M57.18M72.27M59.91M

Capital expenditure

paid out, so below zero

-32.09M-25.47M-19.31M-25.13M

Depreciation and amortisation

18.20M19.36M17.23M16.73M

Free cash flow

operating cash flow plus capital expenditure

24.83M31.71M52.96M34.78M